EBOS Group Limited

EBOS Group Limited

EBOSY

$23.30

Updated: 24/09/2026, 20:42:11

Market Cap
$1.19B
Sector
Healthcare
Industry
Medical - Distribution
Country
AU
Stock valuation chart
One-year closing share-price history for EBOSY
Company Profile

EBOS Group Limited, established in 1922 and headquartered in Docklands, Australia, operates as a prominent marketer, wholesaler, and distributor of a broad spectrum of healthcare, medical, pharmaceutical, and animal care products. Its operations span Australia, New Zealand, and Southeast Asia, structured primarily around its Healthcare and Animal Care divisions. The Healthcare segment offers a comprehensive suite of services and products. These include intricate healthcare logistics, medication management systems, and specialized pharmacy management software. The software solutions cover various aspects such as loyalty programs, generics management, regulatory compliance, business intelligence, and in-store retail operations. EBOS also provides strategic health communications, targeted programs, and expert consultancy. The company is committed to delivering community-focused healthcare initiatives and supplies an extensive array of wellness products, including vitamins, minerals, supplements, herbal teas, natural oral care items, and functional foods like molasses and manuka honey. For independent pharmacies, EBOS offers the "Pharmacy Choice" integrated retail program and "healthSAVE," a community pharmacy banner aimed at bolstering retail business performance. Its client roster for health and wellness products is diverse, encompassing public and private hospitals, day surgery centers, general practices, aged care facilities, specialist clinics, government bodies, and non-profit health agencies, alongside critical clinical supplies. Additionally, EBOS extends its pharmacy services to various institutions, including private and public hospitals, cancer treatment centers, correctional facilities, and veterinary clinics. Further specialized offerings comprise allograft solutions, extensive healthcare distribution and warehousing services, clinical trial management and logistics, product registration support, as well as aesthetic healthcare devices, medical-grade cosmeceuticals, injectables, and a full range of surgical devices and medical consumables. Within the Animal Care segment, EBOS provides a wide selection of pet nutrition, treats, cleaning, and grooming products and accessories. It also functions as a significant wholesaler of veterinary products, catering to companion animals, livestock (production animals), and equine athletes. The company was originally incorporated as Early Bros Dental & Surgical Supplies Ltd. before adopting its current name, EBOS Group Limited, in 1986.

USD
OTC
CEO: Adam Luke Hall
Employees: 5,700
https://www.ebosgroup.com
Asset Summaries
Latest generated summaries for EBOSY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for EBOSY.
Share price
$23.30
Market cap
$1.19B
Exchange
OTC
Currency
USD
CEO
Adam Luke Hall
Employees
5,700
IPO date
11/05/2017
Beta
0.155
Last dividend
$0.00
Day range
$23.30 – $23.30
52-week range
$22.59 – $46.64
1-day performance
0.00%
1-year performance
3.15%
Current drawdown (1Y)
-50.04%
CIK
0001533082
CUSIP
278727102
ISIN
US2787271020
Created
07/12/2025, 03:42:26
Last update
24/09/2026, 20:42:11

Track EBOS Group Limited with an AI analyst

See which prediction-market events move EBOSY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to EBOSY from your Railway `news_articles` table.

No news found for this symbol.